 NeuroMetrix Inc NASDAQ: NURO shares are trading higher by 30.10 at 4.06 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia. Quell Fibromyalgia is a transcutaneous electrical nerve. 